Pune, India -- (SBWIRE) -- 08/30/2018 -- Global Lower GI Series Market - Overview
Gastrointestinal diseases has gained a tremendous attention over the last few years. Increasing prevalence of different gastrointestinal diseases and disorders has encouraged many companies for initiating the research & development for innovative and advanced drugs, diagnostics, and therapeutic approaches.
A Lower Gastrointestinal (GI) Series or Barium Enema test provides a series of X-ray images of the large intestine. A lower Gi series is most commonly used to screen for colorectal cancer and bowel diseases. It is helpful for determining the cause of bleeding, pain, bowel obstruction, or changes in bowel movements. Upon modification of this test to a Double-Contrast Barium Enema, and with the use of fluoroscope, it can be used to view inside the large intestine to provide a better view of the mucous membrane.
According to a recent study report published by the Market Research Future analysts, the global lower Gi series market is currently very steady and growing at a moderate rate. This market is mainly driven by the factors such as increasing prevalence of GI diseases, rising geriatric population and increasing investment in research & development. Additionally, changing lifestyle and increasing awareness about the availability of the treatment fuel the market growth. Having said that, development of an alternative diagnostic tests, and increasing use of colonoscopies may hinder the growth of the lower GI series market to an extent..
The Global Lower GI Series Market is expected to grow at a CAGR of 4.6% during the forecast period 2017-2023.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/771
Key Players for Global Lower GI Series Market
Market Research Future (MRFR) recognizes the following companies as the key players in Lower GI Series Market: There are plenty of large and small market players which operate in this market all over the globe.
The Global Market consist of players such as Eisai Co. Ltd. (Japan), Cadila Pharmaceuticals Limited (India), PeaceHealth (U.S.), Purdue Pharma L.P. (U.S.), Alfasigma SpA (Italy), Mount Sinai Beth (Israel), South Sound Radiology (U.S.), AstraZeneca (U.K.) and Ironwood Pharmaceuticals (U.S.)
Global Lower GI Series Market - Competitive Analysis
The global lower GI series market consists of number of healthcare providers and tests available in the market. The market demonstrates steady growth. Further resulting in intensified competition. Top players are investing heavily in R&D and clinical trials to develop effective procedures for diagnostics in the GI space. There are few developments in the market with respect to lower GI series.
Ironwood Pharmaceuticals, Inc. is a manufacturer of different types of medicines. One of the drugs manufactured by this company is Linaclotide which is approved by the U.S. Food and Drug Administration and marketed since December 2012.
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan, It has launched number of products used as contrast media. In 2016, the company announced partnership with Ajinomoto co., Inc. for the establishment of gastrointestinal specialty Ea Pharma Co.
Regional Analysis for Global Lower GI Series Market
The global lower GI series market is growing at a moderate rate. This market is greatly benefitted by the increased aging population in the major regions all across the world. America region captured a significant share of the global lower GI series market. According to the National Institute of Diabetes and Digestive and Kidney Diseases, more than 34 million Americans have GI tract diseases out of which 20 million American have chronic diseases. According to Federal Interagency Forum, 46 million people over age 65 year lived in the United States in 2014, accounting for 15 percent of the total population. Such huge population in United States which are more prone to the gastrointestinal diseases such as Ulcerative colitis, colon cancer, Crohn's disease, and others have majorly driving the growth of the lower Gi series market in this region.
Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/771
European market is second highest revenue generator after America. Europe lower Gi series market has benefited by the presence of some major healthcare providers, and diagnostic laboratories in this region. Moreover, increasing patient pool for gastrointestinal diseases and changing laboratory practices are driving the growth for Europe lower GI series market.
Asia Pacific region is the fastest growing region in lower GI market owing to the rising population with the gastrointestinal problems. According to the World Cancer Research Fund International (2016), Japan and China rank second and fifth respectively in the incidence of stomach cancer in Asia. With such high rates of stomach cancer, researchers have begun investigating the various environmental and genetic factors that may explain such concerning statistics.
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
TOC Continued…
Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/771
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.